title: Predicting response to HER2 kinase inhibition.
abstract: Comment on: Takagi S, Banno H, Hayashi A, Tamura T, Ishikawa T, Ohta Y. HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285. Oncoscience. 2014; 1:196-204.
authors: Discovery Oncology, Genentech, Inc., South San Francisco, CA.
authors: Jeff
authors: J
authors: Settleman
references: Oncoscience. 2014 Mar 24;1(3):196-204
references: 25594012
references: Future Oncol. 2014 Jun;10(8):1469-86
references: 25052756
references: Clin Chem. 2013 Oct;59(10):1447-56
references: 23656699
references: Curr Cancer Drug Targets. 2010 Dec;10(8):799-812
references: 20718710
references: Cold Spring Harb Symp Quant Biol. 2005;70:419-26
references: 16869779
references: Cancer Cell. 2013 May 13;23(5):603-17
references: 23680147
references: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references: 11252954
references: J Pathol. 2014 Jan;232(2):219-29
references: 24105684